A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod

BACKGROUND: Although the aggregate of data among patients with multiple sclerosis (MS) have shown similar efficacy between dimethyl fumarate (DMF) and fingolimod (FTY), most studies have not assessed long-term worsening of disability. We compared long-term disability worsening over 5 years, as asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Salter, Amber, Lancia, Samantha, Cutter, Gary, Marrie, Ruth Ann, Mendoza, Jason P., Lewin, James B., Fox Mellen, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252399/
https://www.ncbi.nlm.nih.gov/pubmed/34262613
http://dx.doi.org/10.1177/17562864211021177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252399/
https://www.ncbi.nlm.nih.gov/pubmed/34262613
http://dx.doi.org/10.1177/17562864211021177

Ejemplares similares